XML 11 R4.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Operating expenses:        
Research and development $ 3,851 $ 3,546 $ 12,127 $ 10,647
General and administrative 1,767 2,190 6,609 7,385
Total operating expenses 5,618 5,736 18,736 18,032
Loss from operations (5,618) (5,736) (18,736) (18,032)
Change in fair value of financial instruments (2,000) (100) 200 7,790
Interest expense (326) 0 (1,097) 0
Interest income 140 218 562 800
Other income 0 0 269 0
Total other income (expense) (2,186) 118 (66) 8,590
Net loss $ (7,804) $ (5,618) $ (18,802) $ (9,442)
Net loss per share - basic $ (0.52) $ (0.5) $ (1.28) $ (0.88)
Net loss per share - diluted $ (0.52) $ (0.5) $ (1.28) $ (0.88)
Weighted-average number of shares outstanding used in computing net loss per share - basic 15,076,456 11,134,964 14,734,641 10,674,531
Weighted-average number of shares outstanding used in computing net loss per share - diluted 15,076,456 11,134,964 14,734,641 10,674,531